Aditya Birla Capital Limited — Q4 FY24
Aditya Birla Capital delivered a strong Q4 FY24 with consolidated PAT up 41% YoY to INR 2,902 crore and revenue up 30% to INR 39,050 crore.
✓ Verified against BSE filing
Did management answer the analysts?
Every material analyst question, graded on whether management actually answered it — with the verbatim exchange and quantitative claims checked against filed numbers.
ROE guidance for next three years post merger
Asked by Nischint Chawathe, Kotak Institutional Equities
Management explicitly declined to provide ROE guidance despite direct request.
Read the exchange
So what kind of an ROE guidance would you give us for the next three years?
See, Nishant, right now, we are not making any ROE guidance. What we are focused on is that on each one of the businesses, we continue to improve our operating performance.
Rise in GNPA in consumer unsecured business
Asked by Nischint Chawathe, Kotak Institutional Equities
Attributed rise to denominator effect but did not provide static pool delinquency trends.
Read the exchange
We have seen a fairly sharp rise on the sequential and the year-on-year basis. So any color or any commentary on this?
If you look at that, it has gone from 2.2 to 2.9 and 2.2 to 2.8, but that's primarily on the reduction in the book. ... It's a denominator effect, and we haven't seen any increase in delinquency in personal and consumer.
Margin compression in life insurance due to distributor payouts
Asked by Nischint Chawathe, Kotak Institutional Equities
Clearly denied distributor payout impact and attributed to ULIP mix and GSEC rates.
Read the exchange
Is it purely because of the increase in share of units, or would you also kind of say that payouts to distributors have gone up?
It has no impact on margins because of any payout to the distributor that has gone up. ... Largely on two factors. One is that ULIP for the year went to 24%... and the fact that in Q4, the GSEC was lesser...
Details on acquired portfolio of INR 4,500 crore
Asked by Avinash Singh, Emkay Global
Described nature but did not disclose specific lenders or originators.
Read the exchange
If you can just help us understand about sort of what kind of a loan from what kind of a lenders or unitors you have acquired this portfolio.
So these are small-ticket loans against property. Primarily, that's the nature of the business, nature of the loans which we would have acquired. These would be seasoned portfolio where we do 100% sampling, and we cherry-pick the portfolio.
Cost-income ratio trajectory for housing finance in FY25
Asked by Avinash Singh, Emkay Global
Spoke about operating leverage but gave no quantitative cost-income ratio target.
Read the exchange
If you can sort of provide clarity or color on how these cost income ratios are going to behave over the FY 2025?
The idea is as the book grows further, of course, the fixed costs will get apportioned towards the larger book. We'll get an operating leverage in times to come. And of course, then the ROE will stabilize further.
Breakdown of operating and economic variance in life insurance EV
Asked by Avinash Singh, Emkay Global
Gave overall unwind and operating variance contribution but not detailed components.
Read the exchange
If you can just help sort of a breakdown of your operating and economic variance and changing.
So the 18.8% roughly is, yeah, unwind. Obviously, our operating variance has been positive for about contributing 1.5%, and it has been positive for the last three years consecutively.
Additional risk controls for 3X balance sheet growth
Asked by Manoj Bahety, Carnelian Asset Management
Provided specific measures: tightened underwriting, scorecards, collections infrastructure.
Read the exchange
What kind of additional risk controls at a corporate level you have introduced which will tackle your balance sheet, which will be 3X of its size in the next few years.
Tightening of underwriting, tightening of our scorecards, also the collections infrastructure, and the capacity building which we have done in collections.
Path to profitability for health insurance
Asked by Manoj Bahety, Carnelian Asset Management
Gave a clear timeline and target (100% COR by FY26).
Read the exchange
When can we expect this to start contributing on a bottom-line basis?
Yeah. So as I mentioned earlier and even Vijay mentioned that we're looking at 100% COR by FY 2026 in the next 24 months.
Change in distribution strategy for personal loans due to RBI norms
Asked by Manoj Bahety, Carnelian Asset Management
Clearly stated shift to in-house distribution and reduction in BNPL.
Read the exchange
With RBI tightening norms on fintech partners, is there a significant change in our strategy and how we are dealing with the situation?
We are looking at in-house distribution for building our personal and consumer business. ... BNPL, you can see the numbers. That's come down significantly. It's almost negligible at this point in time.
Growth target for NBFC and HFC AUM for FY25
Asked by Anuj Singla, Bank of America
Provided a clear three-year doubling target, though not specific to FY25.
Read the exchange
Have you articulated any numbers there?
We have given a guidance that we will double our loan book in three years. From March 2023 to 2026, we will double our loan book.
NIM trajectory for FY25 given personal loan slowdown
Asked by Anuj Singla, Bank of America
Did not provide any quantitative NIM outlook, only a general statement.
Read the exchange
How should we see the NIMs trajectory maybe for FY 2025?
We should be able to manage both growth and margins.
Texture on acquired portfolio yields and product mix
Asked by Bhaskar Basu, Jefferies
Provided specific yield range for acquired portfolio.
Read the exchange
If you could give a little more texture around these loans, what kind of yields do they generate?
The customer yield will be 11%-12% for these portfolios.
| Claim | Management said | Filing | Verdict |
|---|---|---|---|
| Health insurance profit of INR 88 crore in Q4 FY24 | ₹88 cr | ₹1,288 cr | Understated vs filing |
| Health insurance 42% CAGR growth over last three years | 42% | 30% | Overstated vs filing |
Filed figures sourced from Screener.in. Claims within a small tolerance of the filing are marked “matches filing”.